Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
This study has been completed.
Study NCT00022074 Information provided by National Cancer Institute (NCI)
First Received: August 10, 2001 Last Updated: August 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anxiety Disorder
Breast Cancer
Depression
Hot Flashes
Additional conditions recognized in this trial
Anxiety Disorders
Breast Neoplasms
Depressive Disorder
Disease
More general conditions related to this trial
Behavioral Symptoms
Breast Diseases
Mental Disorders
Mood Disorders
Neoplasms
Neoplasms by Site
Pathologic Processes
Signs and Symptoms
Skin Diseases
Interventions listed in this trial
gabapentin
quality-of-life assessment
More general drug interventions related to this trial
Analgesics
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antimanic Agents
Antiparkinson Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
James P. Wilmot Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
